유럽의 조영제 및 인젝터 시스템 시장 : 분석 및 예측(2022-2026년)

The Europe Contrast Media Agent and Injector System Market Expected to Reach $2,740.6 Million by 2026

Introduction to Europe Contrast Media Agent and Injector System Market

The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026. The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

Market Introduction

The Europe Contrast Media Agent and Injector System market is witnessing robust growth driven by factors such as the increasing prevalence of chronic diseases, rising demand for diagnostic imaging procedures, and advancements in medical imaging technologies. Contrast media agents and injector systems play a crucial role in enhancing the visibility of anatomical structures during imaging procedures such as CT scans, MRI scans, and angiography. With a growing aging population and rising healthcare expenditures, there is a heightened emphasis on early disease detection and accurate diagnosis, further fueling the demand for contrast media agents and injector systems in Europe. Additionally, ongoing research and development activities aimed at improving imaging techniques and patient outcomes are expected to drive market growth. Regulatory initiatives aimed at ensuring patient safety and the availability of innovative imaging solutions also contribute to market expansion in the region.

Market Segmentation:

Segmentation 1: by Product

• Contrast Media Agents
• Injector Systems

Segmentation: Injector Systems (by Product)

• Injector
• Consumables and Accessories

Segmentation 2: by Country

• Germany
• U.K.
• France
• Italy
• Spain
• Rest-of-Europe

How can this report add value to an organization?

Growth/Marketing Strategy: The Europe contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The Europe contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Some of the prominent names established in this market are:

• Bayer AG
• Bracco Group
• Guerbet
• ulrich GmbH & Co. KG

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Markets

• 1.1 Market Outlook
  • 1.1.1 Product Definition
  • 1.1.2 Inclusion and Exclusion Criteria
  • 1.1.3 Key Findings
• 1.2 Market Overview
• 1.3 Industry Outlook
  • 1.3.1 Regulatory and Legal Requirements and Framework
    • 1.3.1.1 Regulatory and Legal Requirements and Framework in Europe
  • 1.3.2 Patent Analysis
    • 1.3.2.1 Patent Filing Trend (by Year)
    • 1.3.2.2 Patent Filing Trend (by Country)
  • 1.3.3 Key Trends
    • 1.3.3.1 Nanoparticle-Based Contrast Agents
    • 1.3.3.2 Development of Safer Contrast Media Agent
    • 1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
• 1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
  • 1.4.1 Pre-COVID-19 Impact
  • 1.4.2 During COVID-19 Impact
  • 1.4.3 Post-COVID-19 Impact
• 1.5 Market Dynamics
  • 1.5.1 Impact Analysis
  • 1.5.2 Market Drivers
    • 1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
    • 1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
    • 1.5.2.3 Growing Number of Regulatory Approvals
  • 1.5.3 Market Restraints
    • 1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
  • 1.5.4 Market Opportunities
    • 1.5.4.1 IT Advances in Contrast Media Injectors

2 Region

• 2.1 Overview
• 2.2 Europe
  • 2.2.1 Key Findings
  • 2.2.2 Market Dynamics
    • 2.2.2.1 Impact Analysis
  • 2.2.3 Market Size and Forecast
    • 2.2.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
      • 2.2.3.1.1 Europe Contrast Media Injector System Market (by Product)
    • 2.2.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
      • 2.2.3.2.1 Germany
        • 2.2.3.2.1.1 Market Sizing and Forecast
        • 2.2.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
      • 2.2.3.2.2 Italy
        • 2.2.3.2.2.1 Market Sizing and Forecast
        • 2.2.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
      • 2.2.3.2.3 France
        • 2.2.3.2.3.1 Market Sizing and Forecast
        • 2.2.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
      • 2.2.3.2.4 U.K.
        • 2.2.3.2.4.1 Market Sizing and Forecast
        • 2.2.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
      • 2.2.3.2.5 Spain
        • 2.2.3.2.5.1 Market Sizing and Forecast
        • 2.2.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
      • 2.2.3.2.6 Rest-of-Europe
        • 2.2.3.2.6.1 Market Sizing and Forecast
        • 2.2.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Competitive Benchmarking
  • 3.1.1 Key Strategies and Development
    • 3.1.1.1 Regulatory and Legal Activities
    • 3.1.1.2 Partnerships, Collaborations, and Business Expansions
    • 3.1.1.3 Mergers and Acquisitions
    • 3.1.1.4 New Offerings
  • 3.1.2 Market Share Analysis
    • 3.1.2.1 Market Share Analysis, by Contrast Media Agent Market
    • 3.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
• 3.2 Contrast Media Ecosystem Active Players
• 3.3 Company Profiles
  • 3.3.1 Bayer AG
    • 3.3.1.1 Company Overview
    • 3.3.1.2 Role of Bayer AG in the Contrast Media Agent and Injector System Market
    • 3.3.1.3 Financials
    • 3.3.1.4 Recent Developments
    • 3.3.1.5 Analyst Perception
  • 3.3.2 Bracco Group
    • 3.3.2.1 Company Overview
    • 3.3.2.2 Role of Bracco Group in the Contrast Media Agent and Injector System Market
    • 3.3.2.3 Recent Developments
    • 3.3.2.4 Analyst Perception
  • 3.3.3 Fresenius SE & Co. KGaA
    • 3.3.3.1 Company Overview
    • 3.3.3.2 Role of Fresenius SE & Co. KGaA in the Contrast Media Agent and Injector System Market
    • 3.3.3.3 Financials
    • 3.3.3.4 Recent Developments
    • 3.3.3.5 Analyst Perception
  • 3.3.4 Guerbet
    • 3.3.4.1 Company Overview
    • 3.3.4.2 Role of Guerbet in the Contrast Media Agent and Injector System Market
    • 3.3.4.3 Financials
    • 3.3.4.4 Recent Developments
    • 3.3.4.5 Analyst Perception
  • 3.3.5 ulrich GmbH & Co. KG
    • 3.3.5.1 Company Overview
    • 3.3.5.2 Role of ulrich GmbH & Co. KG in the Contrast Media Agent and Injector System Market
    • 3.3.5.3 Recent Developments
    • 3.3.5.4 Analyst Perception